title: FDA advisers support rescheduling of hydrocodone products.
authors: Kate
authors: K
authors: Traynor
mesh_terms: D002487:Centers for Disease Control and Prevention, U.S. / Q000331:legislation & jurisprudence / Q000639:trends; D002626:Chemistry, Pharmaceutical / Q000145:classification / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000145:classification / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D006853:Hydrocodone / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence* / Q000639:trends
chemical_list: D006853:Hydrocodone